Co-Infection
(3 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) | |||
Zeile 3: | Zeile 3: | ||
{{tp|p=32297939|t=ä. SARS-CoV-2 and Legionella Co-infection in a Person Returning from a Nile Cruise |pdf=|usr=}} | {{tp|p=32297939|t=ä. SARS-CoV-2 and Legionella Co-infection in a Person Returning from a Nile Cruise |pdf=|usr=}} | ||
{{tp|p=32293646|t=ä. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens |pdf=|usr=}} | {{tp|p=32293646|t=ä. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens |pdf=|usr=}} | ||
− | + | {{tp|p=32475878|t=2020. The first pediatric patients with coronavirus disease 2019 (COVID-19) in Japan; The risk of co-infection with other respiratory viruses.|pdf=|usr=007}} | |
{{tp|p=32192233|t=2020. Co-infection with SARS-CoV-2 and Human Metapneumovirus |pdf=|usr=}} | {{tp|p=32192233|t=2020. Co-infection with SARS-CoV-2 and Human Metapneumovirus |pdf=|usr=}} | ||
{{tp|p=32170625|t=ä. Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients |pdf=|usr=}} | {{tp|p=32170625|t=ä. Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients |pdf=|usr=}} | ||
{{tp|p=32305630|t=ä. A severe case with co-infection of SARS-CoV-2 and common respiratory pathogens |pdf=|usr=}} | {{tp|p=32305630|t=ä. A severe case with co-infection of SARS-CoV-2 and common respiratory pathogens |pdf=|usr=}} | ||
− | + | {{tp|p=32453917|t=2020. SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19?|pdf=|usr=007}} | |
{{tp|p=32173883|t=ä. COVID?19 and mycoplasma pneumoniae coinfection |pdf=|usr=}} | {{tp|p=32173883|t=ä. COVID?19 and mycoplasma pneumoniae coinfection |pdf=|usr=}} | ||
{{tp|p=32314699|t=2020. Case Report: The Importance of Novel Coronavirus Disease (COVID-19) and Coinfection with Other Respiratory Pathogens in the Current Pandemic |pdf=|usr=}} | {{tp|p=32314699|t=2020. Case Report: The Importance of Novel Coronavirus Disease (COVID-19) and Coinfection with Other Respiratory Pathogens in the Current Pandemic |pdf=|usr=}} | ||
Zeile 13: | Zeile 13: | ||
{{ttp|p=32374823|t=2020. COVID-2019 associated overexpressed Prevotella proteins mediated host-pathogen interactions and their role in coronavirus outbreak |pdf=|usr=}} | {{ttp|p=32374823|t=2020. COVID-2019 associated overexpressed Prevotella proteins mediated host-pathogen interactions and their role in coronavirus outbreak |pdf=|usr=}} | ||
{{tp|p=32379863|t=ä. Metagenomic analysis reveals clinical SARS-CoV-2 infection and bacterial or viral superinfection and colonization |pdf=|usr=}} | {{tp|p=32379863|t=ä. Metagenomic analysis reveals clinical SARS-CoV-2 infection and bacterial or viral superinfection and colonization |pdf=|usr=}} | ||
− | + | {{tp|p=32441243|t=2020. Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020.|pdf=|usr=007}} | |
{{tp|p=32301747|t=2020. Coinfection of SARS-CoV-2 and multiple respiratory pathogens in children |pdf=|usr=}} | {{tp|p=32301747|t=2020. Coinfection of SARS-CoV-2 and multiple respiratory pathogens in children |pdf=|usr=}} | ||
{{tp|p=32292053|t=2020. Severe Pneumonia Due to SARS-CoV-2 and Respiratory Syncytial Virus Infection: A Case Report |pdf=|usr=}} | {{tp|p=32292053|t=2020. Severe Pneumonia Due to SARS-CoV-2 and Respiratory Syncytial Virus Infection: A Case Report |pdf=|usr=}} | ||
{{tp|p=32362302|t=ä. To alert coinfection of COVID-19 and dengue virus in developing countries in the dengue-endemic area |pdf=|usr=}} | {{tp|p=32362302|t=ä. To alert coinfection of COVID-19 and dengue virus in developing countries in the dengue-endemic area |pdf=|usr=}} | ||
− | + | {{tp|p=32427361|t=2020. Four cases: Human immunodeficiency virus and novel coronavirus 2019 Co-infection in patients from Long Island, New York.|pdf=|usr=007}} | |
{{tp|p=32339350|t=2020. COVID-19 associated pulmonary aspergillosis |pdf=|usr=}} | {{tp|p=32339350|t=2020. COVID-19 associated pulmonary aspergillosis |pdf=|usr=}} | ||
{{tp|p=32379193|t=2020. A CASE OF CHILDHOOD COVID-19 INFECTION WITH PLEURAL EFFUSION COMPLICATED BY POSSIBLE SECONDARY MYCOPLASMA PNEUMONIAE INFECTION |pdf=|usr=}} | {{tp|p=32379193|t=2020. A CASE OF CHILDHOOD COVID-19 INFECTION WITH PLEURAL EFFUSION COMPLICATED BY POSSIBLE SECONDARY MYCOPLASMA PNEUMONIAE INFECTION |pdf=|usr=}} | ||
Zeile 23: | Zeile 23: | ||
{{tp|p=32376725|t=2020. Co-infection and Other Clinical Characteristics of COVID-19 in Children |pdf=|usr=}} | {{tp|p=32376725|t=2020. Co-infection and Other Clinical Characteristics of COVID-19 in Children |pdf=|usr=}} | ||
{{tp|p=32238260|t=2020. Coinfeccion entre dengue y COVID-19: Necesidad de abordaje en zonas endemicas |pdf=|usr=}} | {{tp|p=32238260|t=2020. Coinfeccion entre dengue y COVID-19: Necesidad de abordaje en zonas endemicas |pdf=|usr=}} | ||
− | + | {{tp|p=32392591|t=2020. SARS CoV-2 und Influenza A-Ko-Infektion bei einem padiatrischen Patienten in Deutschland.|pdf=|usr=007}} | |
− | + | {{tp|p=C7195315|t=2020. Co-infections: potentially lethal and unexplored in COVID-19 |pdf=|usr=}} | |
+ | {{tp|p=32423586|t=2020. SARS-CoV-2 and influenza virus co-infection |pdf=|usr=}} | ||
+ | {{tp|p=32402687|t=ä. Pulmonary infarction secondary to pulmonary thromboembolism in COVID-19 diagnosed with dual-energy CT pulmonary angiography |pdf=|usr=}} | ||
+ | {{tp|p=32503617|t=2020. Clinical characteristics of invasive pulmonary aspergillosis in patients with COVID-19 in Zhejiang, China: a retrospective case series.|pdf=|usr=007}} | ||
{{ttp|p=32265235|t=2020. COVID-19 and Kawasaki Disease: Novel Virus and Novel Case |pdf=|usr=}} | {{ttp|p=32265235|t=2020. COVID-19 and Kawasaki Disease: Novel Virus and Novel Case |pdf=|usr=}} | ||
{{tp|p=32196707|t=ä. The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China |pdf=|usr=}} | {{tp|p=32196707|t=ä. The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China |pdf=|usr=}} | ||
Zeile 30: | Zeile 33: | ||
{{tp|p=32320082|t=2020. Co-detection of respiratory pathogens in patients hospitalized with Coronavirus viral disease-2019 pneumonia |pdf=|usr=}} | {{tp|p=32320082|t=2020. Co-detection of respiratory pathogens in patients hospitalized with Coronavirus viral disease-2019 pneumonia |pdf=|usr=}} | ||
{{tp|p=32293743|t=2020. Coinfection with COVID-19 and Coronavirus HKU1 - the critical need for repeat testing if clinically indicated |pdf=|usr=}} | {{tp|p=32293743|t=2020. Coinfection with COVID-19 and Coronavirus HKU1 - the critical need for repeat testing if clinically indicated |pdf=|usr=}} | ||
+ | {{tp|p=32470211|t=2020. Are we now observing an increasing number of coinfections between SARS-CoV-2 and other respiratory pathogens?|pdf=|usr=007}} | ||
+ | {{tp|p=32441773|t=2020. COVID-19 in a patient with HIV infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32449972|t=2020. Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID-19 and Mycoplasma pneumoniae in the USA.|pdf=|usr=007}} | ||
+ | {{tp|p=32449792|t=2020. Severe SARS-CoV-2 pneumonia in a 58-year-old patient with HIV: a clinical case report from the Republic of Cyprus.|pdf=|usr=007}} | ||
+ | {{tp|p=32462695|t=2020. Coinfection with SARS-CoV-2 and other respiratory pathogens in COVID-19 patients in Guangzhou, China.|pdf=|usr=007}} | ||
+ | {{tp|p=32437000|t=2020. HIV and SARS-CoV-2 coinfection: A case report from Uganda.|pdf=|usr=007}} | ||
+ | {{tp|p=32462663|t=2020. Clinical features and outcome of HIV/SARS-CoV-2 coinfected patients in The Bronx, New York city.|pdf=|usr=007}} | ||
+ | {{tp|p=32505530|t=2020. Co-infection with an atypical pathogen of COVID-19 in a young.|pdf=|usr=007}} | ||
+ | {{tp|p=32448041|t=2020. Covid-19 induced superimposed bacterial infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32393593|t=2020. Recognition and management of respiratory coinfection and secondary bacterial pneumonia in patients with COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32497283|t=2020. Influenza and COVID-19 Co-infection: Report of 6 cases and review of the Literature.|pdf=|usr=007}} | ||
+ | {{tp|p=32492188|t=2020. A case of SARS-CoV-2 infection in an untreated HIV patient in Tokyo, Japan.|pdf=|usr=007}} | ||
+ | {{tp|p=32483000|t=2020. COVID-19 pneumonia in patients with HIV - A Case Series.|pdf=|usr=007}} | ||
+ | {{tp|p=32449248|t=2020. COVID-19 and herpes zoster co-infection presenting with trigeminal neuropathy.|pdf=|usr=007}} | ||
+ | {{tp|p=32404716|t=2020. A case of HIV and SARS-CoV-2 co-infection in Singapore.|pdf=|usr=007}} | ||
+ | {{tp|p=32238235|t=2020. Da Tuberculose ao COVID-19: Legitimidade Juridico-Constitucional do Isolamento/Tratamento Compulsivo por Doencas Contagiosas em Portugal.|pdf=|usr=007}} | ||
+ | {{tp|p=32514399|t=2020. A case of Bacillus cereus bacteremia in a COVID-19 patient treated with steroids.|pdf=|usr=008}} | ||
+ | {{tp|p=32500854|t=2020. Primary Respiratory Bacterial Coinfections in Patients with COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32396381|t=2020. COVID-19 Associated Pulmonary Aspergillosis.|pdf=|usr=007}} | ||
+ | {{tp|p=32501851|t=2020. SARS-CoV-2 infection in a highly experienced person living with HIV.|pdf=|usr=007}} | ||
+ | {{tp|p=32501850|t=2020. Potential impact of COVID-19 in people living with HIV: experience from previous 21st century coronaviruses epidemics.|pdf=|usr=007}} | ||
+ | {{tp|p=32469614|t=2020. A Case Series of Five People Living with HIV Hospitalized with COVID-19 in Chicago, Illinois.|pdf=|usr=007}} | ||
+ | {{tp|p=32407127|t=2020. Why Aren't People Living with HIV at Higher Risk for Developing Severe Coronavirus Disease 2019 (COVID-19)?|pdf=|usr=007}} | ||
+ | {{tp|p=32532935|t=2020. Bacterial and fungal infections among patients with SARS-CoV-2 pneumonia.|pdf=|usr=008}} | ||
+ | {{tp|p=32501397|t=2020. "The ancient and the new": is there an interaction between cytomegalovirus and SARS-CoV-2 infection?|pdf=|usr=008}} | ||
+ | {{tp|p=32412848|t=2020. A Case of COVID-19 and Pneumocystis jirovecii Co-infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32459833|t=2020. Hospitalized patients with COVID-19 and HIV: a case series.|pdf=|usr=007}} | ||
+ | {{tp|p=32415313|t=2020. Clinical features and development of sepsis in patients infected with SARS-CoV-2: a retrospective analysis of 150 cases outside Wuhan, China.|pdf=|usr=008}} | ||
+ | {{tp|p=32472138|t=2020. Clinical characteristics and outcomes in people living with HIV hospitalized for COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32517166|t=2020. Azole-Resistant COVID-19-Associated Pulmonary Aspergillosis in an Immunocompetent Host: A Case Report.|pdf=|usr=008}} | ||
+ | {{tp|p=32488446|t=2020. COVID-19-associated invasive pulmonary aspergillosis.|pdf=|usr=008}} | ||
+ | {{tp|p=32407467|t=2020. Clinical features and outcomes of HIV patients with coronavirus disease 2019.|pdf=|usr=008}} | ||
+ | {{tp|p=32447425|t=2020. Fatal SARS-CoV-2 coinfection in course of EBV-associated lymphoproliferative disease.|pdf=|usr=008}} | ||
+ | {{tp|p=32406606|t=2020. Positive detection of SARS-CoV-2 combined HSV1 and HHV6B virus nucleic acid in tear and conjunctival secretions of a non-conjunctivitis COVID-19 patient with obstruction of common lacrimal duct.|pdf=|usr=008}} | ||
+ | {{tp|p=32535894|t=2020. Bloodstream infections in critically ill patients with COVID-19.|pdf=|usr=008}} | ||
+ | {{tp|p=32530063|t=2020. Herpes zoster in COVID-19-positive patients.|pdf=|usr=008}} | ||
+ | {{tp|p=32530531|t=2020. Are co-infections with COVID-19 and Influenza low or underreported? An observational study examining current published literature including three new unpublished cases.|pdf=|usr=008}} | ||
+ | {{tp|p=32447801|t=2020. Herpes zoster might be an indicator for latent COVID 19 infection.|pdf=|usr=008}} | ||
+ | {{tp|p=32519763|t=2020. The characteristics of two patients coinfected with SARS-CoV-2 and HIV in Wuhan, China.|pdf=|usr=008}} | ||
+ | {{tp|p=32524663|t=2020. Oral lesions of herpes zoster in COVID-19 patients or truly associated to the disease?|pdf=|usr=008}} | ||
+ | {{tp|p=32527756|t=2020. Endocrine changes in SARS-CoV-2 patients and lessons from SARS-CoV.|pdf=|usr=008}} | ||
+ | {{tp|p=32399452|t=2020. Co-infection with Influenza A and COVID-19.|pdf=|usr=008}} | ||
+ | {{tp|p=32399451|t=2020. A Case of Coinfection with SARS-COV-2 and Cytomegalovirus in the Era of COVID-19.|pdf=|usr=008}} | ||
+ | {{tp|p=32457198|t=2020. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.|pdf=|usr=008}} | ||
+ | {{tp|p=32527804|t=2020. COVID-19 and flu, a perfect storm.|pdf=|usr=008}} | ||
+ | {{tp|p=32482787|t=2020. Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital.|pdf=|usr=008}} | ||
+ | {{tp|p=32473235|t=2020. Co-infections in people with COVID-19: a systematic review and meta-analysis.|pdf=|usr=008}} | ||
+ | {{tp|p=32445724|t=2020. Different patterns of Influenza A and B detected during early stages of COVID-19 in a university hospital in Sao Paulo, Brazil.|pdf=|usr=008}} | ||
+ | {{tp|p=32522037|t=2020. A Case Series of Patients Coinfected With Influenza and COVID-19.|pdf=|usr=008}} | ||
+ | {{tp|p=32493147|t=2020. The Coincidence of 2 Epidemics, Coccidioidomycosis and SARS-CoV-2: A Case Report.|pdf=|usr=008}} | ||
+ | {{tp|p=32474045|t=2020. Co-infection of SARS-CoV-2 and Influenza virus in Early Stage of the COVID-19 Epidemic in Wuhan, China.|pdf=|usr=008}} | ||
+ | {{tp|p=32474044|t=2020. COVID-19 Patients with Recent Influenza A/B Infection: A Retrospective Study.|pdf=|usr=008}} | ||
+ | {{tp|p=32160148|t=2020. Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China |pdf=|usr=}} | ||
+ | {{tp|p=32343223|t=2020. Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient |pdf=|usr=}} | ||
+ | {{tp|p=32298228|t=2020. Panton-Valentine Leukocidin-Secreting Staphylococcus aureus Pneumonia Complicating COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32410338|t=2020. Co-infection with COVID-19 and influenza A virus in two died patients with acute respiratory syndrome, Bojnurd, Iran.|pdf=|usr=008}} | ||
+ | {{tp|p=32410319|t=2020. Coronavirus Disease 2019 and Viral Hepatitis coinfection: Provide guidelines for integrated screening and treatment.|pdf=|usr=008}} | ||
+ | {{tp|p=32369240|t=2020. Cutaneous manifestations of a 21st century worldwide fungal epidemic possibly complicating the COVID-19 pandemic to jointly menace mankind |pdf=|usr=}} | ||
+ | {{tp|p=32482367|t=2020. Fungal antigenemia in patients with severe Coronavirus disease 2019 (COVID-19): The facts and challenges.|pdf=|usr=008}} | ||
+ | {{tp|p=32482366|t=2020. Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?|pdf=|usr=008}} | ||
+ | {{tp|p=32401359|t=2020. Recovery from COVID-19 in two patients with coexisted HIV infection.|pdf=|usr=008}} | ||
+ | {{tp|p=32358954|t=ä. Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing |pdf=|usr=}} | ||
+ | {{tp|p=32361747|t=ä. COVID-19, superinfections and antimicrobial development: What can we expect?|pdf=|usr=}} | ||
+ | {{tp|p=32266995|t=2020. Reply to Comments on 'Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China'.|pdf=|usr=008}} | ||
+ | {{tp|p=32242946|t=2020. Comments on "coinfection of SARS-CoV-2 and HIV in a patient in Wuhan city, China".|pdf=|usr=008}} | ||
+ | |||
+ | |||
+ | {{tp|p=32290901|t=2020. Excess cases of influenza-like illnesses synchronous with coronavirus disease (COVID-19) epidemic, France, March 2020 |pdf=|usr=}} | ||
+ | |||
+ | {{tp|p=32368495|t=2020. Co-infection with SARS-CoV-2 and influenza A virus |pdf=|usr=}} | ||
+ | {{tp|p=32368493|t=2020. Co-Infection with SARS-COV-2 and Parainfluenza in a young adult patient with pneumonia: Case Report |pdf=|usr=}} | ||
+ | {{tp|p=32317036|t=ä. Bacterial and fungal infections in COVID-19 patients: A matter of concern |pdf=|usr=}} |
Aktuelle Version vom 12. September 2020, 17:19 Uhr
32307254 ä. Invasive fungal diseases during COVID-19: We should be prepared
32297939 ä. SARS-CoV-2 and Legionella Co-infection in a Person Returning from a Nile Cruise
32293646 ä. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens
32475878 2020. The first pediatric patients with coronavirus disease 2019 (COVID-19) in Japan; The risk of co-infection with other respiratory viruses.
32192233 2020. Co-infection with SARS-CoV-2 and Human Metapneumovirus
32170625 ä. Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients
32305630 ä. A severe case with co-infection of SARS-CoV-2 and common respiratory pathogens
32453917 2020. SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19?
32173883 ä. COVID?19 and mycoplasma pneumoniae coinfection
32314699 2020. Case Report: The Importance of Novel Coronavirus Disease (COVID-19) and Coinfection with Other Respiratory Pathogens in the Current Pandemic
32271596 2020. Co-infection of Coronavirus Disease 2019 and Influenza A: A Report from Iran
32374823 2020. COVID-2019 associated overexpressed Prevotella proteins mediated host-pathogen interactions and their role in coronavirus outbreak |
32379863 ä. Metagenomic analysis reveals clinical SARS-CoV-2 infection and bacterial or viral superinfection and colonization
32441243 2020. Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020.
32301747 2020. Coinfection of SARS-CoV-2 and multiple respiratory pathogens in children
32292053 2020. Severe Pneumonia Due to SARS-CoV-2 and Respiratory Syncytial Virus Infection: A Case Report
32362302 ä. To alert coinfection of COVID-19 and dengue virus in developing countries in the dengue-endemic area
32427361 2020. Four cases: Human immunodeficiency virus and novel coronavirus 2019 Co-infection in patients from Long Island, New York.
32339350 2020. COVID-19 associated pulmonary aspergillosis
32379193 2020. A CASE OF CHILDHOOD COVID-19 INFECTION WITH PLEURAL EFFUSION COMPLICATED BY POSSIBLE SECONDARY MYCOPLASMA PNEUMONIAE INFECTION
32287051 2020. Coinfection of Influenza Virus and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)
32376725 2020. Co-infection and Other Clinical Characteristics of COVID-19 in Children
32238260 2020. Coinfeccion entre dengue y COVID-19: Necesidad de abordaje en zonas endemicas
32392591 2020. SARS CoV-2 und Influenza A-Ko-Infektion bei einem padiatrischen Patienten in Deutschland.
C7195315 2020. Co-infections: potentially lethal and unexplored in COVID-19
32423586 2020. SARS-CoV-2 and influenza virus co-infection
32402687 ä. Pulmonary infarction secondary to pulmonary thromboembolism in COVID-19 diagnosed with dual-energy CT pulmonary angiography
32503617 2020. Clinical characteristics of invasive pulmonary aspergillosis in patients with COVID-19 in Zhejiang, China: a retrospective case series.
32265235 2020. COVID-19 and Kawasaki Disease: Novel Virus and Novel Case |
32196707 ä. The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China
32352574 2020. Co-infection in SARS-CoV-2 infected Patients: Where Are Influenza Virus and Rhinovirus/Enterovirus?
32320082 2020. Co-detection of respiratory pathogens in patients hospitalized with Coronavirus viral disease-2019 pneumonia
32293743 2020. Coinfection with COVID-19 and Coronavirus HKU1 - the critical need for repeat testing if clinically indicated
32470211 2020. Are we now observing an increasing number of coinfections between SARS-CoV-2 and other respiratory pathogens?
32441773 2020. COVID-19 in a patient with HIV infection.
32449972 2020. Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID-19 and Mycoplasma pneumoniae in the USA.
32449792 2020. Severe SARS-CoV-2 pneumonia in a 58-year-old patient with HIV: a clinical case report from the Republic of Cyprus.
32462695 2020. Coinfection with SARS-CoV-2 and other respiratory pathogens in COVID-19 patients in Guangzhou, China.
32437000 2020. HIV and SARS-CoV-2 coinfection: A case report from Uganda.
32462663 2020. Clinical features and outcome of HIV/SARS-CoV-2 coinfected patients in The Bronx, New York city.
32505530 2020. Co-infection with an atypical pathogen of COVID-19 in a young.
32448041 2020. Covid-19 induced superimposed bacterial infection.
32393593 2020. Recognition and management of respiratory coinfection and secondary bacterial pneumonia in patients with COVID-19.
32497283 2020. Influenza and COVID-19 Co-infection: Report of 6 cases and review of the Literature.
32492188 2020. A case of SARS-CoV-2 infection in an untreated HIV patient in Tokyo, Japan.
32483000 2020. COVID-19 pneumonia in patients with HIV - A Case Series.
32449248 2020. COVID-19 and herpes zoster co-infection presenting with trigeminal neuropathy.
32404716 2020. A case of HIV and SARS-CoV-2 co-infection in Singapore.
32238235 2020. Da Tuberculose ao COVID-19: Legitimidade Juridico-Constitucional do Isolamento/Tratamento Compulsivo por Doencas Contagiosas em Portugal.
32514399 2020. A case of Bacillus cereus bacteremia in a COVID-19 patient treated with steroids.
32500854 2020. Primary Respiratory Bacterial Coinfections in Patients with COVID-19.
32396381 2020. COVID-19 Associated Pulmonary Aspergillosis.
32501851 2020. SARS-CoV-2 infection in a highly experienced person living with HIV.
32501850 2020. Potential impact of COVID-19 in people living with HIV: experience from previous 21st century coronaviruses epidemics.
32469614 2020. A Case Series of Five People Living with HIV Hospitalized with COVID-19 in Chicago, Illinois.
32407127 2020. Why Aren't People Living with HIV at Higher Risk for Developing Severe Coronavirus Disease 2019 (COVID-19)?
32532935 2020. Bacterial and fungal infections among patients with SARS-CoV-2 pneumonia.
32501397 2020. "The ancient and the new": is there an interaction between cytomegalovirus and SARS-CoV-2 infection?
32412848 2020. A Case of COVID-19 and Pneumocystis jirovecii Co-infection.
32459833 2020. Hospitalized patients with COVID-19 and HIV: a case series.
32415313 2020. Clinical features and development of sepsis in patients infected with SARS-CoV-2: a retrospective analysis of 150 cases outside Wuhan, China.
32472138 2020. Clinical characteristics and outcomes in people living with HIV hospitalized for COVID-19.
32517166 2020. Azole-Resistant COVID-19-Associated Pulmonary Aspergillosis in an Immunocompetent Host: A Case Report.
32488446 2020. COVID-19-associated invasive pulmonary aspergillosis.
32407467 2020. Clinical features and outcomes of HIV patients with coronavirus disease 2019.
32447425 2020. Fatal SARS-CoV-2 coinfection in course of EBV-associated lymphoproliferative disease.
32406606 2020. Positive detection of SARS-CoV-2 combined HSV1 and HHV6B virus nucleic acid in tear and conjunctival secretions of a non-conjunctivitis COVID-19 patient with obstruction of common lacrimal duct.
32535894 2020. Bloodstream infections in critically ill patients with COVID-19.
32530063 2020. Herpes zoster in COVID-19-positive patients.
32530531 2020. Are co-infections with COVID-19 and Influenza low or underreported? An observational study examining current published literature including three new unpublished cases.
32447801 2020. Herpes zoster might be an indicator for latent COVID 19 infection.
32519763 2020. The characteristics of two patients coinfected with SARS-CoV-2 and HIV in Wuhan, China.
32524663 2020. Oral lesions of herpes zoster in COVID-19 patients or truly associated to the disease?
32527756 2020. Endocrine changes in SARS-CoV-2 patients and lessons from SARS-CoV.
32399452 2020. Co-infection with Influenza A and COVID-19.
32399451 2020. A Case of Coinfection with SARS-COV-2 and Cytomegalovirus in the Era of COVID-19.
32457198 2020. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.
32527804 2020. COVID-19 and flu, a perfect storm.
32482787 2020. Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital.
32473235 2020. Co-infections in people with COVID-19: a systematic review and meta-analysis.
32445724 2020. Different patterns of Influenza A and B detected during early stages of COVID-19 in a university hospital in Sao Paulo, Brazil.
32522037 2020. A Case Series of Patients Coinfected With Influenza and COVID-19.
32493147 2020. The Coincidence of 2 Epidemics, Coccidioidomycosis and SARS-CoV-2: A Case Report.
32474045 2020. Co-infection of SARS-CoV-2 and Influenza virus in Early Stage of the COVID-19 Epidemic in Wuhan, China.
32474044 2020. COVID-19 Patients with Recent Influenza A/B Infection: A Retrospective Study.
32160148 2020. Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China
32343223 2020. Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient
32298228 2020. Panton-Valentine Leukocidin-Secreting Staphylococcus aureus Pneumonia Complicating COVID-19
32410338 2020. Co-infection with COVID-19 and influenza A virus in two died patients with acute respiratory syndrome, Bojnurd, Iran.
32410319 2020. Coronavirus Disease 2019 and Viral Hepatitis coinfection: Provide guidelines for integrated screening and treatment.
32369240 2020. Cutaneous manifestations of a 21st century worldwide fungal epidemic possibly complicating the COVID-19 pandemic to jointly menace mankind
32482367 2020. Fungal antigenemia in patients with severe Coronavirus disease 2019 (COVID-19): The facts and challenges.
32482366 2020. Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?
32401359 2020. Recovery from COVID-19 in two patients with coexisted HIV infection.
32358954 ä. Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing
32361747 ä. COVID-19, superinfections and antimicrobial development: What can we expect?
32266995 2020. Reply to Comments on 'Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China'.
32242946 2020. Comments on "coinfection of SARS-CoV-2 and HIV in a patient in Wuhan city, China".
32290901 2020. Excess cases of influenza-like illnesses synchronous with coronavirus disease (COVID-19) epidemic, France, March 2020
32368495 2020. Co-infection with SARS-CoV-2 and influenza A virus
32368493 2020. Co-Infection with SARS-COV-2 and Parainfluenza in a young adult patient with pneumonia: Case Report
32317036 ä. Bacterial and fungal infections in COVID-19 patients: A matter of concern